Longitudinal Changes in Anger, Anxiety, and Fatigue Are Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease

被引:10
|
作者
Babulal, Ganesh M. [1 ,2 ,3 ,4 ]
Chen, Ling [5 ]
Doherty, Jason M. [1 ]
Murphy, Samantha A. [1 ]
Johnson, Ann M. [6 ]
Roe, Catherine M. [1 ]
机构
[1] Washington Univ, Dept Neurol, St Louis, MO 63110 USA
[2] Washington Univ, Inst Publ Hlth, St Louis, MO 63110 USA
[3] Univ Johannesburg, Fac Humanities, Dept Psychol, Johannesburg, South Africa
[4] George Washington Univ, Sch Med & Hlth Sci, Dept Clin Res & Leadership, Washington, DC 20052 USA
[5] Washington Univ, Div Biostat, St Louis, MO 63110 USA
[6] Washington Univ, Ctr Clin Studies, St Louis, MO 63110 USA
关键词
Alzheimer's disease; anger; anxiety; biomarkers; cerebrospinal fluid; older adults; MILD BEHAVIORAL IMPAIRMENT; COGNITIVE IMPAIRMENT; DEPRESSIVE SYMPTOMS; OLDER-ADULTS; DEMENTIA; TAU; NEURODEGENERATION; PREVALENCE; PROFILE; DECLINE;
D O I
10.3233/JAD-215708
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease (AD) studies in cognitively normal (CN) older adults age >= 65 suggest depression is associated with molecular biomarkers (imaging and cerebrospinal fluid [CSF]). This study used linear mixed models (covariance pattern model) to assess whether baseline CSF biomarkers (A beta(42)/A beta(40), t-Tau/A beta(42) , p-Tau/A beta(42)) predicted changes in non-depressed mood states in CN older adults (N= 248), with an average of three follow-up years. Participants with higher levels of CSF biomarkers developed more anger, anxiety, and fatigue over time compared to those with more normal levels. Non-depressed mood states in preclinical AD may be a prodrome for neuropsychiatric symptoms in symptomatic AD.
引用
收藏
页码:141 / 148
页数:8
相关论文
共 50 条
  • [31] Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer's disease
    Skogseth, Ragnhild
    Mulugeta, Ezra
    Ballard, Clive
    Rongve, Arvid
    Nore, Sabine
    Alves, Guido
    Aarsland, Dag
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2008, 25 (06) : 559 - 563
  • [32] The Impact of Cerebrospinal Fluid Biomarkers on the Diagnosis of Alzheimer's Disease
    Engelborghs, Sebastiaan
    Le Bastardl, Nathalie
    MOLECULAR DIAGNOSIS & THERAPY, 2012, 16 (03) : 135 - 141
  • [33] To tap or not to tap: Cerebrospinal fluid biomarkers of Alzheimer's disease
    Growdon, JH
    ANNALS OF NEUROLOGY, 1998, 44 (01) : 6 - 7
  • [34] Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid
    Riekse, Robert G.
    Li, Ge
    Petrie, Eric C.
    Leverenz, James B.
    Vavrek, Darcy
    Vuletic, Simona
    Albers, John J.
    Montine, Thomas J.
    Lee, Virginia M. -Y.
    Lee, Michael
    Seubert, Peter
    Galasko, Douglas
    Schellenberg, Gerard D.
    Hazzard, William R.
    Peskind, Elaine R.
    JOURNAL OF ALZHEIMERS DISEASE, 2006, 10 (04) : 399 - 406
  • [35] Reply: Cerebrospinal fluid proteomics for biomarkers of Alzheimer's disease
    Lee, Kelvin H.
    Relkin, Norman R.
    ANNALS OF NEUROLOGY, 2007, 61 (05) : 497 - 498
  • [36] A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Belgium
    Somers, Charisse
    Struyfs, Hanne
    Goossens, Joery
    Niemantsverdriet, Ellis
    Luyckx, Jill
    De Roeck, Naomi
    De Roeck, Ellen
    De Vil, Bart
    Cras, Patrick
    Martin, Jean-Jacques
    De Deyn, Peter-Paul
    Bjerke, Maria
    Engelborghs, Sebastiaan
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 54 (01) : 383 - 395
  • [37] Cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
    Kolupaeva, E.
    Zhukova, I.
    Zhukova, N.
    Alifirova, V.
    Izhboldina, O.
    Mironova, Y.
    Latypova, A.
    Nikitina, M.
    Titova, M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 673 - 673
  • [38] Sleep deprivation and cerebrospinal fluid biomarkers for Alzheimer's disease
    Olsson, Martin
    Arlig, Johan
    Hedner, Jan
    Blennow, Kaj
    Zetterberg, Henrik
    SLEEP, 2018, 41 (05)
  • [39] Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
    Hall, Sara
    Surova, Yulia
    Ohrfelt, Annika
    Blennow, Kaj
    Zetterberg, Henrik
    Hansson, Oskar
    MOVEMENT DISORDERS, 2016, 31 (06) : 898 - 905
  • [40] Cerebrospinal fluid biomarkers in Huntington's disease - a longitudinal study
    Niemela, V.
    Sundblom, J.
    Landtblom, A. -M.
    Herman, S.
    Kultema, K.
    Nyholm, D.
    Blennow, K.
    MOVEMENT DISORDERS, 2017, 32 (12) : E8 - E8